Mode
Text Size
Log in / Sign up
N/A N=112 Randomized Double-blind Treatment

The Effect of DSA on Recovery of Anaesthesia in Children

Anesthesia · Depth of Hypnosis Monitoring

Enrolled (actual)
112
Serious AEs
1.0%
Results posted
Mar 2025
Primary outcome: Primary: The Influence of DSA Monitoring on the Speed of Emergence. — 12; 6 minutes — p=0.041

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Narcotrend Monitor (MT MonitorTechnik, Hannover, Germany) (Device)
Age
Pediatric · 0+ yrs
Sex
All
Sponsor
Erasmus Medical Center
Primary completion
Feb 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
The Influence of DSA Monitoring on the Speed of Emergence.
12; 6 0.041 sig
SECONDARY
Total Time From Discontinuation of Anaesthetic Drug Delivery Until Discharge From the Post Anaesthesia Care Unit.
26.5; 18.5 0.066
SECONDARY
The Incidence of Postoperative Delirium
0; 0
SECONDARY
Differences of Depth of Hypnosis During the Procedure, as Measured by the Narcotrend Monitor.
24; 46; 20; 4; 0; 2
SECONDARY
Incidence of Recall of Events During the Procedure (Awareness)
0; 0; 0; 0; 0; 0
SECONDARY
The End-tidal Sevoflurane Concentration
2.3; 1.8 0.001 sig

Summary

In this randomised, blinded study, we will investigate the influence of DSA on recovery from general anaesthesia. DSA monitoring provides continuous information on depth of hypnosis. Based on DSA monitoring dose adjustments of sevoflurane can be made. We expect that this will lead to a faster speed of emergence and recovery.

Eligibility Criteria

Inclusion Criteria

  • Written informed consent of parents/guardians
  • Age ≥6 months and ≤12 years
  • Surgical procedure requiring GA supplemented with caudal analgesia
  • Ability of the parents/guardians to communicate in Dutch

Exclusion Criteria

  • Primary exclusion criteria
  • Withdrawal of informed consent
  • (Chronic) use of drugs influencing the electroencephalogram
  • Use of premedication
  • Known intolerance for sevoflurane
  • Parents/guardians unable to communicate in Dutch
  • Secondary exclusion criteria
  • Protocol violation
  • Data registration failure
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05525104). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search